openPR Logo
Press release

Prostate Cancer Screening Market Estimated to Flourish by 2017 – 2025

08-03-2017 02:02 PM CET | Health & Medicine

Press release from: Persistence Market Research

Prostate Cancer Screening Market Estimated to Flourish by 2017

Prostate cancer is a disease which affects only the male population and the cancer begins in prostate gland in the male reproductive system. Prostate cancer is one of the commonly diagnosed cancer in men. The diagnosis of prostate cancer in men under the age of 50 has less chances comparing to people above 50. The disease is not infectious or contagious. A few risk factors of prostate cancer are, family history, age, diet and lifestyle. Prostate cancer cannot be prevented however individuals can take care of protective factors. Prostate cancer often has no early symptoms however we can conduct a few early tests to diagnose the prostate cancer. Prostate cancer develops from the prostate cell and almost all prostate cancers are adenocarcinomas. Various prostate cancer types include, sarcomas, small cell carcinomas, neuroendocrine tumors, transitional cell carcinomas. Prostate cancer screening is designated with staging and grading, staging determines the extent of the cancer while grading categorizes the type of cancer. Prostate cancer screening via staging can be of three types, localized, locally advances and metastatic. Prostate cancer grading is scored on the basis of low, intermediate and high.

Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/14557

Prostate Cancer Screening Market: Segmentation

Prostate cancer screening market can be segmented on the basis of various tests conducted on a patient to detect the disease, which include:

Physical Exam
Laboratory Tests
Prostate-Specific Antigen (PSA) Blood Test
Imaging TestsTo view complete report @
Transrectal ultrasound (TRUS)
Bone scan
Computed tomography (CT) scan
Magnetic resonance imaging (MRI)
Lymph node biopsy
Positron Emission Tomography
Gleason Score
TNM Score
Genetic Tests
Digital Rectal Exam (DRE)
Biopsy
Fine-Needle Aspiration

Prostate cancer screening can be segmented on the basis of end user industry which is as follows:

Hospitals
Clinics
Research Labs
Cancer Institutes
Diagnostic Centers
Others

Prostate Cancer Screening Market: Dynamics

Prostate Cancer Screening Market is primarily driven by a few key factors such as the patient awareness regarding rising healthcare concerns, acceptance of serum based marker testing for diagnosis of prostate cancer, increasing research for detection of various types of cancers, and prevention of disease. In addition to this Prostate Cancer Screening Market also observes significant growth due to the various government initiatives, and public awareness campaigns. Companies are working on manufacturing innovative products for early prostate cancer detection and these factors are driving the growth of the prostate cancer screening market. Additionally the companies aim to reduce the number of deaths by introducing new prostate cancer tests in the market.

Prostate cancer screening market however faces various challenges such as patient’s going through unnecessary repeated biopsies & screening procedures which requires huge expenditures for early detections, side effects of surgery like urinary incontinence & impotence, risk of over-diagnosis and overtreatment, MRI scans are accurate however are time consuming and costly for patients. Prostate Cancer Screening tests are costly which a major restraint for the market.

Prostate Cancer Screening Market: Region-wise

Based on geography, the Prostate cancer screening market can be segmented into five major regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. At present, North America holds a leading position in the prostate cancer screening market as the incidence of prostate cancer is frequent in African-American population followed by Europe. The major driving factors which have driven the growth of the prostate cancer screening tests market in this region is constantly increasing regulatory scenario monitored by various organizations, such as World Health Organization (WHO) for the safety and health issues, technological advancement in finding new techniques, rise in funding in public and private sector. Following North America, European countries are also anticipated to show steady growth in the prostate cancer screening market. Asia-Pacific region has improved its healthcare scenario by increasing campaigns on prostate cancer awareness and has emerged as a growing player in prostate cancer screening market. The factors which would fuel the growth of prostate cancer screening tests market in Asia-Pacific are increased initiatives from various government & non-government organizations, rising healthcare concerns, and improving healthcare scenario of the region. Prostate cancer screening market would evolve at a rapid rate across the regions however North America would maintain its position in the overall Prostate cancer screening market.

Prostate Cancer Screening Market: Key

Prostate cancer screening market holds huge number of players operating in the segment for years with expertise and experience. Some of the major players operating in the Prostate cancer screening market are Abbott Laboratories, Almac Group, Bayer AG, Beckman Coulter, Inc., bioMérieux SA, General Electric Company, Genomic Health, Mayo Clinic, MDxHealth, Roche Diagnostics, Rosetta Genomics, Thermo Fisher Scientific, Hologic, Inc., Myriad Genetics, Inc. and many others. Prostate cancer screening market has presence of many regional players which have a huge market share in emerging countries.

To view complete report @http://www.persistencemarketresearch.com/market-research/prostate-cancer-screening-market.asp

About Us 
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
 PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prostate Cancer Screening Market Estimated to Flourish by 2017 – 2025 here

News-ID: 654719 • Views:

More Releases from Persistence Market Research

Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview: The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period. Market Size and Growth: The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and
The Global Graphene Market's Striking Growth and Innovative Applications
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities. Get Access To
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analysis, Emerging Trends with Upcoming Developments
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview: The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033. The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation and Industry Size
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products. To obtain the latest market

All 5 Releases


More Releases for Prostate

Prostate 911 Reviews 2021: ( Unrevealed truth) Prostate 911 100% Risk free SCAM …
Benign prostatic hyperplasia is a frequent condition that most guys have to deal with as they get older. Your prostate gland will grow to the measurement of a lemon. It will block the bladder, which will disrupt urine flow. It will motive damage to the urinary tract. It will purpose erectile dysfunction, bladder infection, and kidney problems. More than 50% of men go through from BPH between the age of
Global Prostate Cancer Therapeutics Market
Global Prostate Cancer Therapeutics Market – Industry Analysis and Forecast (2018-2026) –By Product Type, End User, and Region. Global Prostate Cancer Therapeutics Market was valued at US$ 9.21 Bn in 2017 and is expected to reach US$ 16.21 Bn by 2026, at a CAGR of 7.33 % during a forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,
Prostate Cancer Therapeutics Market: Future Perspective Growth In Prostate Cance …
Global Prostate Cancer Therapeutics Market Precision Business Insights (PBI) in its report titled “Global Prostate Cancer Therapeutics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Prostate Cancer Therapeutics Market Prostate is an exocrine
Prostate Biopsy Forceps Market
Global Prostate Biopsy Forceps Market Status and Trend Report offers a comprehensive analysis on Prostate Biopsy Forceps industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Browse Full Report with TOC: http://orbisresearch.com/contacts/request-sample/2072536 Key questions answered by this report include: Worldwide and Regional Market Size of Prostate Biopsy Forceps 2013-2017,
Prostate Cancer - Pipeline Review, H1 2017
Report Hive Market Research Released a New Research Report of 1845 pages on Title " Prostate Cancer - Pipeline Review, H1 2017 "with detailed Analysis, Forecast and Strategies. Prostate Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer - Pipeline Review, H1 2017, provides an overview of the Prostate Cancer (Oncology) pipeline landscape. Prostate cancer is a form of cancer that affects men and
US Prostate Cancer Drug Pipeline Analysis
Prostate cancer has emerged as one of the most commonly diagnosed cancer among men in the US. According to the American Cancer Society, there were close to 242,000 new cases of prostate cancer in the US in 2012, with 28,000 men dying from it. This was an increase from 206,640 men diagnosed with the condition during 2009. The number of men being actively treated for prostrate disorders such as benign